Lupus nephritis - world health organization (WHO) class III

Clinical trials for Lupus nephritis - world health organization (WHO) class III explained in plain language.

Never miss a new study

Get alerted when new Lupus nephritis - world health organization (WHO) class III trials appear

Sign up with your email to follow new studies for Lupus nephritis - world health organization (WHO) class III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Terminated 1

New lupus pill ONT01 enters human safety trials

Disease control Recruiting now

This early-phase study tests whether a new drug called ONT01 is safe for people with lupus nephritis or systemic lupus erythematosus (SLE). About 61 participants will receive ONT01 alongside their usual lupus medications. The goal is to find the highest safe dose and see if it im…

Matched conditions: LUPUS NEPHRITIS - WORLD HEALTH ORGANIZATION (WHO) CLASS III

Early phase 1 • Sponsor: Hospital for Special Surgery, New York • Aim: Disease control

Last updated Jun 27, 2026 07:58 UTC

Lupus nephritis - world health organization (WHO) class III

Get alerted when new Lupus nephritis - world health organization (WHO) class III trials appear

New lupus pill ONT01 enters human safety trials